-
Product Insights
Systolic Heart Failure - Drugs In Development, 2024
Empower your strategies with our Systolic Heart Failure – Drugs In Development, 2024 report and make more profitable business decisions. Systolic heart failure is a cardiovascular disorder marked by specific features, including the enlargement of the heart's ventricles, resulting in reduced ejection fraction, a measure of the heart's pumping efficiency. This condition can manifest as either a chronic, long-term issue or an acute, sudden onset event. However, in both forms, a critical factor contributing to the progression of systolic heart failure...
-
Product Insights
Venous (Vein) Thrombosis - Drugs In Development, 2024
Empower your strategies with our Venous (Vein) Thrombosis – Drugs In Development, 2024 report and make more profitable business decisions. Venous thromboembolism (VTE) is a condition characterized by the formation of blood clots in veins, encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT typically manifests in deep veins, commonly in the lower leg, thigh, or pelvis, and can extend to the arms, particularly with intravenous central lines. Pulmonary embolism occurs when a detached clot travels to the lungs. With...
-
Product Insights
Subarachnoid Hemorrhage - Drugs In Development, 2024
Empower your strategies with our Subarachnoid Hemorrhage – Drugs In Development, 2024 report and make more profitable business decisions. Subarachnoid hemorrhage refers to the occurrence of bleeding within the subarachnoid space, the region between the brain and its delicate covering tissues. This condition demands immediate medical intervention due to its emergent nature. Causes encompass diverse factors, including arteriovenous malformations (AVMs), bleeding disorders, cerebral aneurysms, head injuries, and the use of blood thinners. The hallmark symptom is a sudden and severe headache,...
-
Product Insights
Arrhythmias - Drugs In Development, 2024
Empower your strategies with our Arrhythmias – Drugs In Development, 2024 report and make more profitable business decisions. An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. Signs and symptoms include anxiety, weakness, dizziness, and light-headedness; fainting or nearly fainting; sweating; shortness of breath; and chest pain. Treatment includes anti-arrhythmics and anticoagulants. The Arrhythmias drugs in development market research report provide...
-
Product Insights
Acute Coronary Syndrome - Drugs In Development, 2024
Empower your strategies with our Acute Coronary Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Acute coronary syndrome (ACS) encompasses ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina, constituting a subset of coronary heart disease (CHD) responsible for a third of deaths in individuals over 35. Unlike some asymptomatic forms of CHD, ACS is always symptomatic. Diagnosis begins with an ECG, crucial for distinguishing between STEMI, NSTEMI, and unstable angina. Initial ACS...
-
Product Insights
Acute Heart Failure - Drugs In Development, 2024
Empower your strategies with our Acute Heart Failure – Drugs In Development, 2024 report and make more profitable business decisions. Acute heart failure (AHF) is a critical medical condition characterized by a sudden onset or rapid worsening of symptoms related to the heart's inability to pump blood effectively. This leads to insufficient oxygen delivery to tissues and organs. AHF can manifest as either new-onset heart failure or exacerbation of chronic heart failure. Common symptoms include shortness of breath, fatigue, and fluid...
-
Product Insights
Deep Vein Thrombosis (DVT) - Drugs In Development, 2024
Empower your strategies with our Deep Vein Thrombosis (DVT) – Drugs In Development, 2024 report and make more profitable business decisions. Deep vein thrombosis (DVT) is a blood clot that forms in a vein deep inside a part of the body. It mainly affects the large veins in the lower leg and thigh. Symptoms include changes in skin color (redness), leg pain, leg swelling (edema), and skin that feels warm to the touch. The predisposing factors include age, smoking, inheriting a...
-
Product Insights
Resistant Hypertension - Drugs In Development, 2024
Empower your strategies with our Resistant Hypertension – Drugs In Development, 2024 report and make more profitable business decisions. Resistant hypertension is defined as hypertension that is poorly responsive to treatment and requires the use of multiple medications to achieve acceptable blood pressure ranges. It may be a consequence of secondary hypertension or have no identifiable cause. Resistant hypertension substantially increases the risk of heart attack, stroke and kidney failure The Resistant Hypertension drugs in development market research report provide comprehensive...
-
Product Insights
Septic Shock - Drugs In Development, 2024
Empower your strategies with our Septic Shock – Drugs In Development, 2024 report and make more profitable business decisions. Septic shock, the most severe complication of sepsis, occurs in response to an inciting agent, which causes both pro-inflammatory and anti-inflammatory immune system activation. It involves very low blood pressure, an altered mental state, and organ dysfunction. Sepsis syndromes are often caused by multidrug-resistant bacterial strains such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), among others. The Septic Shock drugs in...
-
Product Insights
Angina (Angina Pectoris) - Drugs In Development, 2024
Empower your strategies with our Angina (Angina Pectoris) – Drugs In Development, 2024 report and make more profitable business decisions. Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs with exertion and is relieved by rest. Angina generally is a symptom of coronary artery disease. In most severe cases, it occurs with minimal effort or at rest. Symptoms include anxiety, increased or irregular heart rate, paleness and cold sweat, and a feeling of doom....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.